Aurinia Pharmaceuticals
AUPH
#4834
Rank
A$2.75 B
Marketcap
A$21.42
Share price
-3.54%
Change (1 day)
70.11%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2026 (TTM): A$0.20 Billion

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are A$0.29 Billion. In 2025 the company made an earning of A$0.16 Billion, an increase over its 2024 earnings that were of A$17.21 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.20 B23.54%
2025 A$0.16 B864.64%
2024 A$17.21 M-116.44%
2023 -A$0.11 Billion-31.8%
2022 -A$0.16 Billion-39.4%
2021 -A$0.26 Billion61.9%
2020 -A$0.16 Billion-9.73%
2019 -A$0.18 Billion92.65%
2018 -A$89.97 Million36.39%
2017 -A$65.97 Million106.29%
2016 -A$31.98 Million-15.4%
2015 -A$37.8 Million65.84%
2014 -A$22.8 Million129.82%
2013 -A$9.92 Million-26.6%
2012 -A$13.52 Million
2010 -A$7.65 Million-39.22%
2009 -A$12.59 Million-43.78%
2008 -A$22.39 Million-53.19%
2007 -A$47.83 Million42.97%
2006 -A$33.46 Million-23.03%
2005 -A$43.47 Million36.1%
2004 -A$31.94 Million172.57%
2003 -A$11.72 Million484.61%
2002 -A$2.01 Million
2000 -A$9.52 Million453.81%
1999 -A$1.72 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regeneron Pharmaceuticals
REGN
A$7.22 B 3,636.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
-A$31.01 Million-116.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-A$7.69 Million-103.97%๐Ÿ‡บ๐Ÿ‡ธ USA